{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:11:02Z","timestamp":1787508662670,"version":"build-2736575974"},"reference-count":55,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,19]]},"DOI":"10.31744\/einstein_journal\/2023ao0117","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T07:08:34Z","timestamp":1671606514000},"source":"Crossref","is-referenced-by-count":8,"title":["Immunophenotypic characterization of acute leukemias in Bahia, Brazil"],"prefix":"10.31744","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3561-8938","authenticated-orcid":false,"given":"Mariane Melo dos","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4425-3582","authenticated-orcid":false,"given":"Allan Souza dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0378-4130","authenticated-orcid":false,"given":"Herbert Henrique de Melo","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8266-7815","authenticated-orcid":false,"given":"Lorene da Silva","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4727-4805","authenticated-orcid":false,"given":"Roberto Jos\u00e9 Meyer","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0167-4619","authenticated-orcid":false,"given":"Alex Jos\u00e9 Leite","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16942","reference":[{"key":"key20221221070822_B1","author":"Brasil","unstructured":"1. Brasil. Minist\u00e9rio da Sa\u00fade. Instituto Nacional de C\u00e2ncer (INCA). Estimativa 2020. Rio de Janeiro: INCA; s.d. [citado 2022 Mar 29]. Dispon\u00edvel em: https:\/\/www.inca.gov.br\/estimativa\/taxas-ajustadas\/leucemias","journal-title":"Estimativa 2020"},{"key":"key20221221070822_B2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.10","article-title":"Acute myeloid leukaemia","volume":"2","author":"Khwaja","year":"2016","unstructured":"2. Khwaja A, Bjorkholm M, Gale RE, Levine RL, Jordan CT, Ehninger G, et al. Acute myeloid leukaemia. Nat Rev Dis Primers. 2016;2:16010. Review.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"key20221221070822_B3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.mpmed.2017.02.010","article-title":"Acute leukaemia","volume":"45","author":"Mwirigi","year":"2017","unstructured":"3. Mwirigi A, Dillon R, Raj K. Acute leukaemia. Medicine. 2017;45(5):280-6.","journal-title":"Medicine"},{"issue":"4","key":"key20221221070822_B4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/bjh.12425","article-title":"Survival and cure of acute myeloid leukaemia in England, 1971-2006: a population-based study","volume":"162","author":"Shah","year":"2013","unstructured":"4. Shah A, Andersson TM, Rachet B, Bj\u00f6rkholm M, Lambert PC. Survival and cure of acute myeloid leukaemia in England, 1971-2006: a population-based study. Br J Haematol. 2013;162(4):509-16.","journal-title":"Br J Haematol"},{"key":"key20221221070822_B5","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues: WHO classification of tumours","author":"Swerdlow","year":"2017","unstructured":"5. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al, editors. WHO classification of tumours of haematopoietic and lymphoid tissues: WHO classification of tumours, revised 4th edition, volume 2. Geneva: WHO; 2017.","edition":"4th"},{"issue":"3","key":"key20221221070822_B6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00277-016-2846-0","article-title":"Acute promyelocytic leukaemia is highly frequent among acute myeloid leukaemias in Brazil: a hospital-based cancer registry study from 2001 to 2012","volume":"96","author":"Thuler","year":"2017","unstructured":"6. Thuler LC, Pombo-de-Oliveira MS. Acute promyelocytic leukaemia is highly frequent among acute myeloid leukaemias in Brazil: a hospital-based cancer registry study from 2001 to 2012. Ann Hematol. 2017;96(3):355-62.","journal-title":"Ann Hematol"},{"issue":"1","key":"key20221221070822_B7","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2018.002","article-title":"Molecular heterogeneity in acute promyelocytic leukemia - a single center experience from India","volume":"10","author":"Rabade","year":"2018","unstructured":"7. Rabade N, Raval G, Chaudhary S, Subramanian PG, Kodgule R, Joshi S, et al. Molecular heterogeneity in acute promyelocytic leukemia - a single center experience from India. Mediterr J Hematol Infect Dis. 2018;10(1):e2018002.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"2","key":"key20221221070822_B8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.clim.2014.12.008","article-title":"Semi-automated and standardized cytometric procedures for multi-panel and multi-parametric whole blood immunophenotyping","volume":"157","author":"Hasan","year":"2015","unstructured":"8. Hasan M, Beitz B, Rouilly V, Libri V, Urrutia A, Duffy D, Cassard L, Di Santo JP, Mottez E, Quintana-Murci L, Albert ML, Rogge L; Milieu Int\u00e9rieur Consortium. Semi-automated and standardized cytometric procedures for multi-panel and multi-parametric whole blood immunophenotyping. Clin Immunol. 2015; 157(2):261-76.","journal-title":"Clin Immunol"},{"issue":"1","key":"key20221221070822_B9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5858\/2010-0387-RAR.1","article-title":"Multiparameter flow cytometry in the diagnosis and management of acute leukemia","volume":"135","author":"Peters","year":"2011","unstructured":"9. Peters JM, Ansari MQ. Multiparameter flow cytometry in the diagnosis and management of acute leukemia. Arch Pathol Lab Med. 2011;135(1):44-54. Review.","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"key20221221070822_B10","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2014.073","article-title":"Diagnosis and subclassification of acute lymphoblastic leukemia","volume":"6","author":"Chiaretti","year":"2014","unstructured":"10. Chiaretti S, Zini G, Bassan R. Diagnosis and subclassification of acute lymphoblastic leukemia. Mediterr J Hematol Infect Dis. 2014;6(1):e2014073. Review.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"2","key":"key20221221070822_B11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.12816\/0004537","article-title":"Immunophenotypic diagnosis of acute lymphoblastic leukemia using flow cytometry; experience at King Hussein Medical Center","volume":"21","author":"Haddad","year":"2014","unstructured":"11. Haddad F, Wraikat A, Khasawneh R, Kamal N. Immunophenotypic diagnosis of acute lymphoblastic leukemia using flow cytometry; experience at King Hussein Medical Center. J Royal Med Serv. 2014;21(2):21-6.","journal-title":"J Royal Med Serv"},{"issue":"1","key":"key20221221070822_B12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10238-009-0067-8","article-title":"Aberrant phenotypes in childhood and adult acute leukemia and its association with adverse prognostic factors and clinical outcome","volume":"10","author":"Bhushan","year":"2010","unstructured":"12. Bhushan B, Chauhan PS, Saluja S, Verma S, Mishra AK, Siddiqui S, et al. Aberrant phenotypes in childhood and adult acute leukemia and its association with adverse prognostic factors and clinical outcome. Clin Exp Med. 2010;10(1):33-40.","journal-title":"Clin Exp Med"},{"issue":"9","key":"key20221221070822_B13","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"van Dongen","year":"2012","unstructured":"13. van Dongen JJ, Lhermitte L, B\u00f6ttcher S, Almeida J, van der Velden VH, Flores-Montero J, Rawstron A, Asnafi V, L\u00e9crevisse Q, Lucio P, Mejstrikova E, Szczepa\u0144ski T, Kalina T, de Tute R, Br\u00fcggemann M, Sedek L, Cullen M, Langerak AW, Mendon\u00e7a A, Macintyre E, Martin-Ayuso M, Hrusak O, Vidriales MB, Orfao A; EuroFlow Consortium (EU-FP6, LSHB-CT-2006-018708). EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia. 2012;26(9):1908-75.","journal-title":"Leukemia"},{"issue":"7","key":"key20221221070822_B14","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/sj.leu.2402504","article-title":"Antigen expression patterns reflecting genotype of acute leukemias","volume":"16","author":"Hrus\u00e1k","year":"2002","unstructured":"14. Hrus\u00e1k O, Porwit-MacDonald A. Antigen expression patterns reflecting genotype of acute leukemias. Leukemia. 2002;16(7):1233-58. Review.","journal-title":"Leukemia"},{"key":"key20221221070822_B15","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-5-38","article-title":"Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens","volume":"5","author":"Kalina","year":"2005","unstructured":"15. Kalina T, Vaskova M, Mejstrikova E, Madzo J, Trka J, Stary J, et al. Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens. BMC Cancer. 2005;5:38.","journal-title":"BMC Cancer"},{"issue":"3","key":"key20221221070822_B16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.32635\/2176-9745.RBC.2004v50n3.2022","article-title":"Freq\u00fc\u00eancia de imunofen\u00f3tipos aberrantes em leucemias agudas","volume":"50","author":"Emerenciano","year":"2004","unstructured":"16. Emerenciano M, Bossa Y, Zanrosso CW, Alencar DM, Campos MM, Dobbin J, et al. Freq\u00fc\u00eancia de imunofen\u00f3tipos aberrantes em leucemias agudas. Rev Bras Cancerol. 2004;50(3):183-9.","journal-title":"Rev Bras Cancerol"},{"issue":"3","key":"key20221221070822_B17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood-2016-07-726307","article-title":"Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia","volume":"129","author":"Theunissen","year":"2017","unstructured":"17. Theunissen P, Mejstrikova E, Sedek L, van der Sluijs-Gelling AJ, Gaipa G, Bartels M, Sobral da Costa E, Kotrov\u00e1 M, Novakova M, Sonneveld E, Buracchi C, Bonaccorso P, Oliveira E, Te Marvelde JG, Szczepanski T, Lhermitte L, Hrusak O, Lecrevisse Q, Grigore GE, Fro\u0148kov\u00e1 E, Trka J, Br\u00fcggemann M, Orfao A, van Dongen JJ, van der Velden VH; EuroFlow Consortium. Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia. Blood. 2017;129(3):347-57.","journal-title":"Blood"},{"issue":"10230","key":"key20221221070822_B18","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute lymphoblastic leukaemia","volume":"395","author":"Malard","year":"2020","unstructured":"18. Malard F, Mohty M. Acute lymphoblastic leukaemia. Lancet. 2020;395(10230): 1146-62. Review.","journal-title":"Lancet"},{"issue":"2","key":"key20221221070822_B19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12288-011-0110-2","article-title":"Flowcytometric immunophenotypic profile of acute leukemia: mansoura experience","volume":"28","author":"Salem","year":"2012","unstructured":"19. Salem DA, Abd El-Aziz SM. Flowcytometric immunophenotypic profile of acute leukemia: mansoura experience. Indian J Hematol Blood Transfus. 2012;28(2):89-96.","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"2","key":"key20221221070822_B20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/0019-509X.13053","article-title":"Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital","volume":"40","author":"Ghosh","year":"2003","unstructured":"20. Ghosh S, Shinde SC, Kumaran GS, Sapre RS, Dhond SR, Badrinath Y, et al. Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital. Indian J Cancer. 2003;40(2):71-6.","journal-title":"Indian J Cancer"},{"key":"key20221221070822_B21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","unstructured":"21. Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev. 2019;36:70-87. Review.","journal-title":"Blood Rev"},{"key":"key20221221070822_B22","author":"United States of America","unstructured":"22. United States of America. U.S. Department of Health and Human Services. National Institutes of Health. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. SEER Cancer Statistics Review (CSR) 1975-2016. Bethesda: NCI; s.d. [cited 2022 Mar 29]. Available from: https:\/\/seer.cancer.gov\/archive\/csr\/1975_2016","journal-title":"Surveillance, Epidemiology, and End Results Program. SEER Cancer Statistics Review (CSR) 1975-2016"},{"issue":"12","key":"key20221221070822_B23","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1080\/10428190701713622","article-title":"Estimated number of cases, regional distribution and survival of patients diagnosed with acute myeloid leukemia between 1996 and 2000 in Rio Grande do Sul, Brazil","volume":"48","author":"Capra","year":"2007","unstructured":"23. Capra M, Vilella L, Pereira WV, Coser VM, Fernandes MS, Schilling MA, et al. Estimated number of cases, regional distribution and survival of patients diagnosed with acute myeloid leukemia between 1996 and 2000 in Rio Grande do Sul, Brazil. Leuk Lymphoma. 2007;48(12):2381-6.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"key20221221070822_B24","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.hoc.2017.08.006","article-title":"Acute leukemia","volume":"31","author":"Rose-Inman","year":"2017","unstructured":"24. Rose-Inman H, Kuehl D. Acute leukemia. Hematol Oncol Clin North Am. 2017;31(6):1011-28. Review.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"key20221221070822_B25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10552-007-9097-2","article-title":"Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002","volume":"19","author":"Yamamoto","year":"2008","unstructured":"25. Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002. Cancer Causes Control. 2008;19(4):379-90.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"key20221221070822_B26","doi-asserted-by":"crossref","first-page":"e2019017","DOI":"10.4084\/mjhid.2019.017","article-title":"Spectrum and immunophenotypic profile of acute leukemia: a tertiary center flow cytometry experience","volume":"11","author":"Gupta","year":"2019","unstructured":"26. Gupta N, Pawar R, Banerjee S, Brahma S, Rath A, Shewale S, et al. Spectrum and immunophenotypic profile of acute leukemia: a tertiary center flow cytometry experience. Mediterr J Hematol Infect Dis. 2019;11(1):e2019017.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"3","key":"key20221221070822_B27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1309\/C38D-D8J3-JU3E-V6EE","article-title":"The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination","volume":"117","author":"Thalhammer-Scherrer","year":"2002","unstructured":"27. Thalhammer-Scherrer R, Mitterbauer G, Simonitsch I, Jaeger U, Lechner K, Schneider B, et al. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination. Am J Clin Pathol. 2002;117(3):380-9.","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"key20221221070822_B28","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/sj.leu.2401067","article-title":"Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia","volume":"12","author":"Venditti","year":"1998","unstructured":"28. Venditti A, Del Poeta G, Buccisano F, Tamburini A, Cox-Froncillo MC, Aronica G, et al. Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia. Leukemia. 1998;12(7):1056-63.","journal-title":"Leukemia"},{"issue":"4","key":"key20221221070822_B29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/(SICI)1096-8652(199808)58:4<278::AID-AJH5>3.0.CO;2-N","article-title":"Biologic and clinical significance of CD7 expression in acute myeloid leukemia","volume":"58","author":"Saxena","year":"1998","unstructured":"29. Saxena A, Sheridan DP, Card RT, McPeek AM, Mewdell CC, Skinnider LF. Biologic and clinical significance of CD7 expression in acute myeloid leukemia. Am J Hematol. 1998;58(4):278-84.","journal-title":"Am J Hematol"},{"issue":"1","key":"key20221221070822_B30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.yexmp.2005.02.003","article-title":"Aberrant expression of CD7, CD56, and CD79a antigens in acute myeloid leukemias","volume":"79","author":"Cruse","year":"2005","unstructured":"30. Cruse JM, Lewis RE, Pierce S, Lam J, Tadros Y. Aberrant expression of CD7, CD56, and CD79a antigens in acute myeloid leukemias. Exp Mol Pathol. 2005;79(1):39-41.","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"key20221221070822_B31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7314\/APJCP.2014.15.1.221","article-title":"Clinical significance of co-expression of aberrant antigens in acute leukemia: a retrospective cohort study in Makah Al Mukaramah, Saudi Arabia","volume":"15","author":"Abdulateef","year":"2014","unstructured":"31. Abdulateef NA, Ismail MM, Aljedani H. Clinical significance of co-expression of aberrant antigens in acute leukemia: a retrospective cohort study in Makah Al Mukaramah, Saudi Arabia. Asian Pac J Cancer Prev. 2014;15(1):221-7.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"8","key":"key20221221070822_B32","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/sj.leu.2402174","article-title":"CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis","volume":"15","author":"Raspadori","year":"2001","unstructured":"32. Raspadori D, Damiani D, Lenoci M, Rondelli D, Testoni N, Nardi G, et al. CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis. Leukemia. 2001;15(8):1161-4.","journal-title":"Leukemia"},{"issue":"4","key":"key20221221070822_B33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ajh.2830320408","article-title":"Natural killer lymphocyte blast crisis of chronic myelogenous leukemia","volume":"32","author":"Warzynski","year":"1989","unstructured":"33. Warzynski MJ, White C, Golightly MG, Steingart R, Otto RN, Podgurski AE, et al. Natural killer lymphocyte blast crisis of chronic myelogenous leukemia. Am J Hematol. 1989;32(4):279-86.","journal-title":"Am J Hematol"},{"issue":"1","key":"key20221221070822_B34","first-page":"31","article-title":"Immunophenotypic characteristics of the blast crisis in chronic myeloid leukemia","volume":"49","author":"L\u00f3pez-Karpovitch","year":"1997","unstructured":"34. L\u00f3pez-Karpovitch X, C\u00e1rdenas R, Piedras J. Immunophenotypic characteristics of the blast crisis in chronic myeloid leukemia. Rev Invest Clin. 1997;49(1):31-6. Review.","journal-title":"Rev Invest Clin"},{"issue":"23","key":"key20221221070822_B35","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","unstructured":"35. Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374(23):2209-21.","journal-title":"N Engl J Med"},{"key":"key20221221070822_B36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.biopha.2017.10.100","article-title":"Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy","volume":"97","author":"Acheampong","year":"2018","unstructured":"36. Acheampong DO, Adokoh CK, Asante DB, Asiamah EA, Barnie PA, Bonsu DO, et al. Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy. Biomed Pharmacother. 2018;97:225-32. Review.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"key20221221070822_B37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ctrv.2010.02.003","article-title":"Epidemiology of childhood cancer","volume":"36","author":"Kaatsch","year":"2010","unstructured":"37. Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev. 2010; 36(4):277-85. Review.","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"key20221221070822_B38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3322\/caac.21314","article-title":"Cancer statistics for Hispanics\/Latinos, 2015","volume":"65","author":"Siegel","year":"2015","unstructured":"38. Siegel RL, Fedewa SA, Miller KD, Goding-Sauer A, Pinheiro PS, Martinez-Tyson D, et al. Cancer statistics for Hispanics\/Latinos, 2015. CA Cancer J Clin. 2015;65(6):457-80.","journal-title":"CA Cancer J Clin"},{"issue":"16","key":"key20221221070822_B39","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","unstructured":"39. Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373(16):1541-52. Review.","journal-title":"N Engl J Med"},{"issue":"9","key":"key20221221070822_B40","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/leu.2012.121","article-title":"EuroFlow: resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine","volume":"26","author":"van Dongen","year":"2012","unstructured":"40. van Dongen JJ, Orfao A; EuroFlow Consortium. EuroFlow: resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine. Leukemia. 2012;26(9):1899-907.","journal-title":"Leukemia"},{"issue":"1","key":"key20221221070822_B41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.leukres.2013.10.008","article-title":"Significance of CD66c expression in childhood acute lymphoblastic leukemia","volume":"38","author":"Kiyokawa","year":"2014","unstructured":"41. Kiyokawa N, Iijima K, Tomita O, Miharu M, Hasegawa D, Kobayashi K, et al. Significance of CD66c expression in childhood acute lymphoblastic leukemia. Leuk Res. 2014;38(1):42-8.","journal-title":"Leuk Res"},{"issue":"1","key":"key20221221070822_B42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1751-553X.2010.01254.x","article-title":"CD66c expression in B-cell acute lymphoblastic leukemia: strength and weakness","volume":"33","author":"Guillaume","year":"2011","unstructured":"42. Guillaume N, Penther D, Vaida I, Gruson B, Harrivel V, Claisse JF, et al. CD66c expression in B-cell acute lymphoblastic leukemia: strength and weakness. Int J Lab Hematol. 2011;33(1):92-6.","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"key20221221070822_B43","article-title":"Membranous expression of pan CD66, CD66a, CD66b, and CD66c and their clinical impact in acute leukemia: cross sectional longitudinal cohort study in Saudi Arabia","volume":"5","author":"Ismail","year":"2017","unstructured":"43. Ismail MM, Zaghloul A, Abdulateef NA, Morsi HK. Membranous expression of pan CD66, CD66a, CD66b, and CD66c and their clinical impact in acute leukemia: cross sectional longitudinal cohort study in Saudi Arabia. J Leuk (Los Angel). 2017;5(2):1000230.","journal-title":"J Leuk (Los Angel)"},{"key":"key20221221070822_B44","volume-title":"Caracteriza\u00e7\u00e3o hematol\u00f3gica e imunofenot\u00edpica em pacientes com leucemia linfobl\u00e1stica aguda","author":"Alves","year":"2012","unstructured":"44. Alves GV. Caracteriza\u00e7\u00e3o hematol\u00f3gica e imunofenot\u00edpica em pacientes com leucemia linfobl\u00e1stica aguda [tese]. Natal: Universidade Federal do Rio Grande do Norte; 2012. 233 p."},{"issue":"1","key":"key20221221070822_B45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/IR:34:1:13","article-title":"Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis","volume":"34","author":"Furness","year":"2006","unstructured":"45. Furness SG, McNagny K. Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis. Immunol Res. 2006;34(1):13-32. Review.","journal-title":"Immunol Res"},{"issue":"1","key":"key20221221070822_B46","first-page":"31","article-title":"Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression","volume":"82","author":"Cascavilla","year":"1997","unstructured":"46. Cascavilla N, Musto P, D\u2019Arena G, Ladogana S, Matera R, Carotenuto M. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression. Haematologica. 1997;82(1):31-7.","journal-title":"Haematologica"},{"issue":"2","key":"key20221221070822_B47","first-page":"249","article-title":"CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia","volume":"9","author":"Thomas","year":"1995","unstructured":"47. Thomas X, Archimbaud E, Charrin C, Magaud JP, Fiere D. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia. Leukemia. 1995;9(2):249-53.","journal-title":"Leukemia"},{"key":"key20221221070822_B48","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-016-0080-5","article-title":"CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia","volume":"4","author":"Jiang","year":"2016","unstructured":"48. Jiang Z, Wu D, Lin S, Li P. CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia. Biomark Res. 2016;4:23. Review.","journal-title":"Biomark Res"},{"issue":"6","key":"key20221221070822_B49","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1590\/S0100-879X2007000600002","article-title":"Acute leukemia in early childhood","volume":"40","author":"Emerenciano","year":"2007","unstructured":"49. Emerenciano M, Koifman S, Pombo-de-Oliveira MS. Acute leukemia in early childhood. Braz J Med Biol Res. 2007;40(6):749-60. Review.","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"key20221221070822_B50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/leu.2017.213","article-title":"The MLL recombinome of acute leukemias in 2017","volume":"32","author":"Meyer","year":"2018","unstructured":"50. Meyer C, Burmeister T, Gr\u00f6ger D, Tsaur G, Fechina L, Renneville A, et al. The MLL recombinome of acute leukemias in 2017. Leukemia. 2018;32(2):273-84.","journal-title":"Leukemia"},{"issue":"7","key":"key20221221070822_B51","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.clml.2017.05.012","article-title":"Outcome and clinical significance of immunophenotypic markers expressed in different treatment protocols of pediatric patients with T-ALL in developing countries","volume":"17","author":"Sayed","year":"2017","unstructured":"51. Sayed DM, Sayed HA, Raslan HN, Ali AM, Zahran A, Al-Hayek R, et al. Outcome and clinical significance of immunophenotypic markers expressed in different treatment protocols of pediatric patients with T-ALL in developing countries. Clin Lymphoma Myeloma Leuk. 2017;17(7):443-9.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"key20221221070822_B52","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4103\/JLP.JLP_35_18","article-title":"Correlation of expression of aberrant immunophenotypic markers in T-ALL with its morphology: a pilot study","volume":"10","author":"Garg","year":"2018","unstructured":"52. Garg N, Kotru M, Kumar D, Pathak R, Sikka M. Correlation of expression of aberrant immunophenotypic markers in T-ALL with its morphology: a pilot study. J Lab Physicians. 2018;10(4):410-3.","journal-title":"J Lab Physicians"},{"issue":"3","key":"key20221221070822_B53","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/ejh.12238","article-title":"Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL","volume":"92","author":"Chopra","year":"2014","unstructured":"53. Chopra A, Bakhshi S, Pramanik SK, Pandey RM, Singh S, Gajendra S, et al. Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL. Eur J Haematol. 2014;92(3):211-8.","journal-title":"Eur J Haematol"},{"issue":"8","key":"key20221221070822_B54","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V85.8.2025.bloodjournal8582025","article-title":"A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811","volume":"85","author":"Larson","year":"1995","unstructured":"54. Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. Blood. 1995;85(8):2025-37.","journal-title":"Blood"},{"issue":"4","key":"key20221221070822_B55","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2141.2010.08246.x","article-title":"Prognostic factors in adult acute lymphoblastic leukaemia","volume":"150","author":"Rowe","year":"2010","unstructured":"55. Rowe JM. Prognostic factors in adult acute lymphoblastic leukaemia. Br J Haematol. 2010;150(4):389-405. Review.","journal-title":"Br J Haematol"}],"container-title":["einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T05:41:49Z","timestamp":1701582109000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/immunophenotypic-characterization-of-acute-leukemias-in-bahia-brazil\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,19]]},"references-count":55,"alternative-id":["10.31744\/einstein_journal\/2023AO0117"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2023ao0117","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"value":"1679-4508","type":"print"},{"value":"2317-6385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,19]]},"article-number":"eAO0117"}}